Browsing by Author "Pekcan, Sevgi"
Now showing items 1-4 of 4
-
Clinical features and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosis
Sismanlar Eyuboglu, Tugba; Dogru, Deniz; Cakir, Erkan; Cobanoglu, Nazan; Pekcan, Sevgi; Cinel, Guzin; Basaran, Abdurrahman Erdem (Wiley, 9999)Background Pseudo-Bartter syndrome (PBS) is a rare complication of cystic fibrosis (CF) and there are limited data in the literature about it. We aimed to compare clinical features and accompanying findings of patients ... -
Cystic fibrosis in Turkey: First data from the national registry
Dogru, Deniz; Cakir, Erkan; Sismanlar, Tugba; Cobanoglu, Nazan; Pekcan, Sevgi; Cinel, Guzin; Basaran, Abdurrahman E. (Wiley, 2020)Background Cystic fibrosis (CF) care has been implemented in Turkey for a long time; however, there had been no patient registry. For this purpose, the Turkish National CF Registry was established. We present the first ... -
Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey
Cobanoglu, Fatma Nazan; Ersoz, Deniz Dogru; Cakir, Erkan; Eyuboglu, Tugba Sismanlar; Pekcan, Sevgi; Cinel, Guzin; Basaran, Abdurrahman Erdem (European Respiratory Soc Journals Ltd, 2019)… -
Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
Cobanoglu, Nazan; Ozcelik, Ugur; Cakir, Erkan; Eyuboglu, Tugba Sismanlar; Pekcan, Sevgi; Cinel, Guzin; Celebioglu, Ebru (Wiley, 9999)Background A better understanding of cystic fibrosis transmembrane conductance regulator biology has led to the development of modulator drugs such as ivacaftor, lumacaftor-ivacaftor, tezacaftor-ivacaftor, and elexacafto ...
